Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

DESFERRIOXAMINE: A MAJOR ADVANCE IN TREATING DIALYSIS OSTEOMALACIA?

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    DESFERRIOXAMINE: A MAJOR ADVANCE IN TREATING DIALYSIS OSTEOMALACIA?. Inpharma Wkly. 354, 10–11 (1982). https://doi.org/10.1007/BF03297462

    Download citation

    Keywords

    • Metronidazole
    • Sulphasalazine
    • Infectious Mononucleosis
    • Desferrioxamine
    • Faecal Streptococcus